GlassScriptPhysician profile
Joseph Parks
NPI 1639580574
$2,565.87
in general payments reported to CMS, 2019-2025
22 companies · $1,472 in 2025
The $1,472 reported for 2025 was more than what 80% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $298 · 2023: $478 · 2024: $166 · 2025: $1,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $341.66 | 2022-2025 | Eterna |
| Nevro Corp. | $258.50 | 2021-2023 | Senza |
| Boston Scientific Corporation | $249.74 | 2023-2025 | General - Therapies, Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $248.69 | 2022-2025 | Inceptiv |
| Protega Pharmaceutials INC | $228.67 | 2025 | Roxybond |
| Abbvie INC. | $206.70 | 2024-2025 | |
| Globus Medical, INC. | $154.24 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.93 | 2025 | Relistor |
| Forte Bio-Pharma LLC | $137.26 | 2025 | Prolate, Tanlor, Nalocet |
| Si-Bone, INC. | $123.61 | 2023 | |
| Spr Therapeutics, INC | $112.78 | 2023 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $73.16 | 2024-2025 | Belbuca |
| Stryker Corporation | $60.49 | 2025 | Mild Device Kit, Optablate |
| Sonex Health, INC. | $41.59 | 2021 | |
| Biotronik Nro, INC. | $37.08 | 2024 | Prospera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $24.49 | 2025 | Nalu Neurostimulation System |
| Curonix LLC | $21.88 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $20.35 | 2025 | |
| Merz Pharmaceuticals, LLC | $19.54 | 2025 | Xeomin |
| Lundbeck LLC | $19.36 | 2025 | Vyepti |
| Pfizer INC. | $16.36 | 2025 | |
| Scilex Pharmaceuticals INC. | $15.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Parks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.